Patient (n = 30) | Age (y) | Sex | Primary tumor site | Underlying lung disease | Central deposition of Technegas |
1 | 79 | M | LUL | Severe emphysema | Present |
2 | 80 | F | LUL | None | Absent |
3 | 61 | M | LLL | None | Absent |
4 | 79 | F | LUL | None | Present |
5 | 62 | F | RLL | Moderate emphysema | Absent |
6 | 53 | F | RML | Severe emphysema | Present |
7 | 73 | M | LUL | Severe emphysema | Present |
8 | 70 | M | RLL | Severe emphysema | Present |
9 | 74 | M | RUL | Severe emphysema | Absent |
10 | 79 | F | LUL | None | Absent |
11 | 52 | F | Mediastinum | None | Absent |
12 | 65 | M | LUL | Severe emphysema | Absent |
13 | 63 | M | RLL | Moderate emphysema | Absent |
14 | 75 | F | RUL | None | Absent |
15 | 60 | F | RUL | None | Absent |
16 | 70 | M | RLL | Severe emphysema | Absent |
17 | 69 | M | LLL | Severe emphysema | Present |
18 | 69 | M | LUL | Moderate emphysema | Absent |
19 | 56 | M | RUL | Severe emphysema | Present |
20 | 75 | M | LUL | Multifocal infiltrates | Absent |
21 | 69 | M | LUL | Severe emphysema | Present |
22 | 69 | F | RLL | None | Absent |
23 | 65 | F | RUL and RLL | None | Absent |
24 | 80 | M | LUL | Moderate emphysema | Absent |
25 | 74 | M | RLL | Moderate emphysema | Absent |
26 | 70 | M | LLL | Severe emphysema | Present |
27 | 64 | F | RLL | Moderate emphysema | Present |
28 | 56 | F | RLL | None | Absent |
29* | 55 | F | LUL | Severe emphysema | Present |
30 | 67 | F | LUL | None | Present |
↵* Excluded patient.
LUL = left upper lobe; LLL = left lower lobe; RLL = right lower lobe; RML = right middle lobe; RUL = right upper lobe.